ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near Cincinnati, OH, USA:

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Cincinnati, Ohio, United States and 42 other locations

Locations recently updated

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Enrolling
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Blue Ash, Ohio, United States and 30 other locations

Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic...

Enrolling
Diabetic Foot Ulcer
Venous Leg Ulcer
Other: Amnion-Chorion-Amnion
Procedure: Standard of Care

Phase 4

Cellution Biologics

Cincinnati, Ohio, United States and 4 other locations

Multi-Center, Prospective, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Topically Applied PEP-TISSEEL in Subjects with Diabetic...

Enrolling
Diabetic Foot Ulcer
Biological: PEP (Purified Exosome Product) / TISSEEL

Phase 2

Rion LLC

Blue Ash, Ohio, United States

it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 day...

Enrolling
Type 2 Diabetes Mellitus
Drug: LY3209590

Phase 1

Lilly
Lilly

Cincinnati, Ohio, United States and 10 other locations

Locations recently updated

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

Cincinnati, Ohio, United States and 119 other locations

This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...

Active, not recruiting
Diabetic Macular Edema
Drug: Aflibercept
Drug: Iluvien 0.19 MG Drug Implant

Phase 4

Alimera Sciences

Cincinnati, Ohio, United States and 39 other locations

This study will look at how well a new medicine called NNC0519-0130 helps people with type 2 diabetes lower their blood sugar and body weigh...

Enrolling
Diabetes Mellitus, Type 2
Drug: Trizepatide
Drug: NNC0519-0130

Phase 2

Novo Nordisk
Novo Nordisk

Cincinnati, Ohio, United States and 92 other locations

of LY3841136 for chronic weight management alone or in combination with Tirzepatide across a wide dose range in participants with Type 2 Diabetes...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: LY3841136

Phase 2

Lilly
Lilly

Cincinnati, Ohio, United States of America and 50 other locations

New

The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes...

Begins enrollment this month
Type 2 Diabetes
Drug: LY3457263
Drug: Placebo

Phase 2

Lilly
Lilly

Dayton, Ohio, United States and 55 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems